PHARMACYTE BIOTECH, INC. Impairment of Long-Lived Assets Held-for-use
PHARMACYTE BIOTECH, INC. (PMCB) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 9-month period ending 2020-01-31, per its 10-Q filed 2020-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2020-03-13
- PHARMACYTE BIOTECH, INC. impairment of long-lived assets held-for-use for the quarter ending 2020-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. impairment of long-lived assets held-for-use for the quarter ending 2019-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. impairment of long-lived assets held-for-use for the quarter ending 2018-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. impairment of long-lived assets held-for-use for the quarter ending 2018-07-31 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month |
|---|---|---|---|
| 2020-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | $0.00 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $0.00 10-Q · filed 2019-12-23 | ||
| 2019-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 10-Q · filed 2020-03-13 |
| 2018-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | $0.00 10-Q · filed 2019-12-23 | |
| 2018-07-31 | $0.00 10-Q · filed 2018-09-12 | ||
| 2018-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 10-Q · filed 2019-03-14 |
| 2017-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | $0.00 10-Q · filed 2018-12-14 | |
| 2017-07-31 | $0.00 10-Q · filed 2018-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |